Alex Therapeutics raises EUR3.5m in oversubscribed financing round from VC investors
Stockholm-based Digital Therapeutics (DTx) company Alex Therapeutics today announces it has secured EUR3.5 million in a funding round led by European life science venture fund Hadean Ventures and joined by Scale Capital and Bonit Capital. Alex Therapeutics aspires to become the global go-to partner for pharma, and other life-science companies